Aakaar Medical Technologies (NSE:AAKAAR) Beneish M-Score: -1.25 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AAKAAR Aakaar Medical Technologies Ltd NSE:AAKAAR
20 GF Score
Price ₹70.20
! 3 Warning Signs
View Full Analysis

What is Aakaar Medical Technologies Beneish M-Score?

Aakaar Medical Technologies NSE:AAKAAR -1.06% 20 Beneish M-Score is -1.25 as of Jul. 15, 2026. GuruFocus rates NSE:AAKAAR with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 763 Medical Devices & Instruments companies, Aakaar Medical Technologies ranks worse than 89.25% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.25 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Aakaar Medical Technologies's Beneish M-Score or its related term are showing as below:

NSE:AAKAAR' s Beneish M-Score Range Over the Past 10 Years
Min: -1.25   Med: -0.75   Max: -0.58
Current: -1.25

During the past 5 years, the highest Beneish M-Score of Aakaar Medical Technologies was -0.58. The lowest was -1.25. And the median was -0.75.

Aakaar Medical Technologies Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Aakaar Medical Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aakaar Medical Technologies Beneish M-Score Chart

Aakaar Medical Technologies Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
0.00 0.00 -0.58 -0.75 -1.25

Aakaar Medical Technologies Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Beneish M-Score Get a 7-Day Free Trial -0.58 0.00 -0.75 0.00 -1.25

NSE:AAKAAR vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Aakaar Medical Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aakaar Medical Technologies Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aakaar Medical Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Aakaar Medical Technologies's Beneish M-Score falls into.


NSE:AAKAAR
20GF Score
Aakaar Medical Technologies Ltd NSE:AAKAAR
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aakaar Medical Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Aakaar Medical Technologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2168+0.528 * 0.9914+0.404 * 0.8573+0.892 * 1.0879+0.115 * 0.8206
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.984+4.679 * 0.188864-0.327 * 0.5437
=-1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹372.6 Mil.
Revenue was ₹669.0 Mil.
Gross Profit was ₹386.8 Mil.
Total Current Assets was ₹766.1 Mil.
Total Assets was ₹794.2 Mil.
Property, Plant and Equipment(Net PPE) was ₹1.7 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1.3 Mil.
Selling, General, & Admin. Expense(SGA) was ₹50.8 Mil.
Total Current Liabilities was ₹238.8 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.0 Mil.
Net Income was ₹66.4 Mil.
Gross Profit was ₹0.0 Mil.
Cash Flow from Operations was ₹-83.6 Mil.
 Total Receivables was ₹281.4 Mil.
Revenue was ₹615.0 Mil.
Gross Profit was ₹352.5 Mil.
Total Current Assets was ₹518.4 Mil.
Total Assets was ₹541.6 Mil.
Property, Plant and Equipment(Net PPE) was ₹2.3 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1.2 Mil.
Selling, General, & Admin. Expense(SGA) was ₹47.5 Mil.
Total Current Liabilities was ₹299.6 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.0 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(372.586 / 669.038) / (281.443 / 614.957)
=0.556898 / 0.457663
=1.2168

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(352.46 / 614.957) / (386.798 / 669.038)
=0.573146 / 0.578141
=0.9914

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (766.121 + 1.694) / 794.166) / (1 - (518.355 + 2.281) / 541.597)
=0.033181 / 0.038702
=0.8573

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=669.038 / 614.957
=1.0879

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.248 / (1.248 + 2.281)) / (1.283 / (1.283 + 1.694))
=0.353641 / 0.430971
=0.8206

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(50.84 / 669.038) / (47.491 / 614.957)
=0.07599 / 0.077227
=0.984

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 238.83) / 794.166) / ((0 + 299.564) / 541.597)
=0.300731 / 0.553112
=0.5437

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(66.376 - 0 - -83.613) / 794.166
=0.188864

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Aakaar Medical Technologies has a M-score of -1.25 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.25 mean?
Aakaar Medical Technologies (NSE:AAKAAR) has a Beneish M-Score of -1.25 as of Jul. 15, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Aakaar Medical Technologies and its competitors. According to the industry distribution chart, Aakaar Medical Technologies ranks #681 out of 763 companies in the Medical Devices & Instruments industry, placing it in the top 89.3%.
Is Aakaar Medical Technologies' Beneish M-Score too high?
Aakaar Medical Technologies' current Beneish M-Score is -1.25. Based on the distribution chart, Aakaar Medical Technologies ranks #681 out of 763 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Aakaar Medical Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aakaar Medical Technologies ranks #681 out of 763 companies for Beneish M-Score. This places Aakaar Medical Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Aakaar Medical Technologies and its competitors. Aakaar Medical Technologies's current Beneish M-Score is -1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current Beneish M-Score of -1.25. The current Beneish M-Score is -1.25. Aakaar Medical Technologies' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current Beneish M-Score is -1.25 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aakaar Medical Technologies Business Description

Address Telli Galli Cross Road, A - 801, Heritage Plaza, Andheri East, Mumbai, MH, IND, 400 069
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
20GF Score

Get the complete analysis for NSE:AAKAAR

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹70.20
Price